Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Bruna R, Benedetti F, Boccomini C, Patti C, Barbui AM, Pulsoni A, Musso M, Liberati AM, Gini G, Castellino C, Rossini F, Ciceri F, Rota-Scalabrini D, Stelitano C, Di Raimondo F, Tucci A, Devizzi L, Zoli V, Zallio F, Narni F, Dondi A, Parvis G, Semenzato G, Lanza F, Perrone T, Angrilli F, Billio A, Gueli A, Mantoan B, Rambaldi A, Gianni AM, Corradini P, Passera R, Ladetto M, Tarella C.

Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2.

Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma.

Pellicelli A, Giannelli V, Zoli V, Pellicelli V, Zignego AL.

Clin Exp Hepatol. 2018 Sep;4(3):197-200. doi: 10.5114/ceh.2018.78124. Epub 2018 May 10.

3.

Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.

Cox MC, Musuraca G, Battistini R, Casaroli I, Zoli V, Anticoli-Borza P, Arcari A, Naso V, di Landro F, Fabbri F, Tafuri A, Bocci G, Merli F.

Br J Haematol. 2018 Dec;183(5):819-822. doi: 10.1111/bjh.15039. Epub 2017 Nov 28. No abstract available.

PMID:
29193017
4.

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.

Cortelazzo S, Tarella C, Gianni AM, Ladetto M, Barbui AM, Rossi A, Gritti G, Corradini P, Di Nicola M, Patti C, Mulé A, Zanni M, Zoli V, Billio A, Piccin A, Negri G, Castellino C, Di Raimondo F, Ferreri AJ, Benedetti F, La Nasa G, Gini G, Trentin L, Frezzato M, Flenghi L, Falorio S, Chilosi M, Bruna R, Tabanelli V, Pileri S, Masciulli A, Delaini F, Boschini C, Rambaldi A.

J Clin Oncol. 2016 Nov 20;34(33):4015-4022. doi: 10.1200/JCO.2016.67.2980. Epub 2016 Oct 31.

5.

Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma.

Pellicelli AM, Marignani M, Zoli V, Romano M, Morrone A, Nosotti L, Barbaro G, Picardi A, Gentilucci UV, Remotti D, D'Ambrosio C, Furlan C, Mecenate F, Mazzoni E, Majolino I, Villani R, Andreoli A, Barbarini G.

World J Hepatol. 2011 Nov 27;3(11):278-84. doi: 10.4254/wjh.v3.i11.278.

6.

Role of ribavirin in hepatitis flare in HCV-infected patients with B cell non Hodgkin's lymphoma treated with rituximab-containing regimens.

Pellicelli AM, Zoli V.

Dig Liver Dis. 2011 Jun;43(6):501-2. doi: 10.1016/j.dld.2010.12.018. Epub 2011 Apr 1. No abstract available.

PMID:
21459059
7.

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma.

Tarella C, Passera R, Magni M, Benedetti F, Rossi A, Gueli A, Patti C, Parvis G, Ciceri F, Gallamini A, Cortelazzo S, Zoli V, Corradini P, Carobbio A, Mulé A, Bosa M, Barbui A, Di Nicola M, Sorio M, Caracciolo D, Gianni AM, Rambaldi A.

J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.

PMID:
21189387
8.

Ocular adnexal lymphoma and infectious agents.

Pellicelli AM, Zoli V, Remotti D.

Indian J Ophthalmol. 2009 Jan-Feb;57(1):72-3; author reply 73. No abstract available.

9.

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma.

Arcaini L, Montanari F, Alessandrino EP, Tucci A, Brusamolino E, Gargantini L, Cairoli R, Bernasconi P, Passamonti F, Bonfichi M, Zoli V, Bottelli C, Calatroni S, Troletti D, Merli M, Pascutto C, Majolino I, Rossi G, Morra E, Lazzarino M.

Ann Oncol. 2008 Jul;19(7):1331-5. doi: 10.1093/annonc/mdn044. Epub 2008 Mar 15.

PMID:
18344536
10.

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

Gallamini A, Zaja F, Patti C, Billio A, Specchia MR, Tucci A, Levis A, Manna A, Secondo V, Rigacci L, Pinto A, Iannitto E, Zoli V, Torchio P, Pileri S, Tarella C.

Blood. 2007 Oct 1;110(7):2316-23. Epub 2007 Jun 20.

11.

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).

Tarella C, Zanni M, Di Nicola M, Patti C, Calvi R, Pescarollo A, Zoli V, Fornari A, Novero D, Cabras A, Stella M, Comino A, Remotti D, Ponzoni M, Caracciolo D, Ladetto M, Magni M, Devizzi L, Rosato R, Boccadoro M, Bregni M, Corradini P, Gallamini A, Majolino I, Mirto S, Gianni AM; Gruppo Italiano Terapie Innovative nei Linfomi.

Leukemia. 2007 Aug;21(8):1802-11. Epub 2007 Jun 7.

PMID:
17554382
12.

Moist toilet papers as possible sensitizers: review of the literature and evaluation of commercial products in Italy.

Zoli V, Tosti A, Silvani S, Vincenzi C.

Contact Dermatitis. 2006 Oct;55(4):252-4. Review. No abstract available.

PMID:
16958930
13.

Allergic contact cheilitis.

Zoli V, Silvani S, Vincenzi C, Tosti A.

Contact Dermatitis. 2006 May;54(5):296-7. No abstract available.

PMID:
16689817
14.

Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.

Monfardini S, Aversa SM, Zoli V, Salvagno L, Bianco A, Bordonaro R, Benevolo G, Crugnola M, Crivellari G, Vivaldi P, Basso U, Torri V.

Ann Oncol. 2005 Aug;16(8):1352-8. Epub 2005 Apr 27.

PMID:
15857841
15.

Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.

Santini G, Chisesi T, Nati S, Porcellini A, Zoli V, Rizzoli V, Zupo S, Marino G, Rubagotti A, Polacco A, Spriano M, Vimercati R, Congiu AM, Ravetti JL, Aversa S, Candela M, Patti C.

Leuk Lymphoma. 2004 Jun;45(6):1141-7.

PMID:
15359993
16.

Primary cardiac lymphoma: report of two cases occurring in immunocompetent subjects.

Anghel G, Zoli V, Petti N, Remotti D, Feccia M, Pino P, Majolino I.

Leuk Lymphoma. 2004 Apr;45(4):781-8. Review.

PMID:
15160956
17.

Recombinant interleukin-2 treatment before and after autologous stem cell transplantation in hematologic malignancies: clinical and immunologic effects.

De Laurenzi A, Iudicone P, Zoli V, De Rosa L, Guglielmetti M, Pescarollo A, Papetti C, Pacilli L, Lapponi P, Petti N, et al.

J Hematother. 1995 Apr;4(2):113-20.

PMID:
7633841
18.

Blood stem cells autografts in patients with high risk multiple myeloma.

Montuoro A, De Rosa L, Zoli V, Pandolfi A, Cossutta M, Lanti T, De Laurenzi A.

Haematologica. 1990 Jan-Feb;75 Suppl 1:65-9.

PMID:
1972131
19.

Blood stem cell autografts in patients with high risk multiple myeloma.

De Rosa L, Montuoro A, Zoli V, Lanti T, Cossutta M, De Laurenzi A.

Bone Marrow Transplant. 1990 Jan;5 Suppl 1:58-9. No abstract available.

PMID:
1969317
20.

A peculiar case of relapse followed by remission after bone marrow transplantation for chronic myeloid leukemia.

De Laurenzi A, Petti N, Pescarollo A, De Rosa L, Montuoro A, Pacilli L, Ruscio C, Zoli V.

Clin Transpl. 1989:317. No abstract available.

PMID:
2487593
21.

Phenotype of chronic lymphocytic leukemia (CLL) B-cells. B-CLL cells express the Leu-8 antigen.

Cafaro A, Napolitano M, Zoli V, Pacilli L, Mezzaroma I, De Laurenzi A, Pandolfi F.

Blut. 1987 Jan;54(1):43-9.

PMID:
3099866
22.

B-chronic lymphocytic leukemia with cells binding sheep erythrocytes during prolymphocytoid transformation.

Pacilli L, Cochi S, Ferraro P, Fioravanti D, Ingletto D, Pavan A, Zoli V, Angeloni P, De Laurenzi A, Mannella E.

Haematologica. 1985 May-Jun;70(3):250-3. No abstract available.

PMID:
3932156
23.

Unusual phenotype (Leu 7+, OKT4+, OKM1+) expressed by cells from a patient with an abnormal expansion of granular lymphocytes.

Quinti I, Pacilli L, Zoli V, De Sanctis G, Mannella E, Bonomo G, De Laurenzi A, Pandolfi F.

Acta Haematol. 1984;71(5):310-5.

PMID:
6429996

Supplemental Content

Support Center